Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...

Pharmacokinetics in Pediatric Patients: Drug Metabolism

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...

Pharmacokinetics in Pediatric Patients: Drug Excretion

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...

Pharmacokinetics in Pediatric Patients: Drug Distribution

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...

Drug Dosing: Infants and Children

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Autism spectrum disorder diagnosis using a new panel of immune- and inflammatory-related serum biomarkers: A case-control multicenter study.

Frontiers in pediatrics·2023

Same author

Universal healthcare as pandemic preparedness: The lives and costs that could have been saved during the COVID-19 pandemic.

Proceedings of the National Academy of Sciences of the United States of America·2022

Same author

Exacerbation of COVID-19 mortality by the fragmented United States healthcare system: A retrospective observational study.

Lancet regional health. Americas·2022

Same author

Capacity building in nutrition science: revisiting the curricula for medical professionals.

Annals of the New York Academy of Sciences·2013

Same author

The role of probiotics in the prevention and treatment of antibiotic-associated diarrhea and Clostridium difficile colitis.

Gastroenterology clinics of North America·2012

Same author

Preface: clinical applications of probiotics in gastroenterology: questions and answers.

Gastroenterology clinics of North America·2012

Search research articles

Related Experiment Video

Updated: Jun 17, 2026

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache

Published on: June 2, 2014

Advances in paediatric migraine.

Gerald Friedman¹

¹Department of Paediatrics, York Central Hospital, Richmond Hill, Ontario.

Paediatrics & Child Health

|January 5, 2010

Summary

Pediatric migraine is common, with most cases being primary headaches. Triptans, a serotonin agonist medication, are effective for treating acute migraines in children, aligning with adult treatment standards.

Area of Science:

Pediatric Neurology
Neuroscience
Pharmacology

Background:

Headaches are a frequent pediatric primary care complaint.
Most childhood headaches are primary syndromes like migraine or tension-type.
Parental concern often involves fear of serious underlying pathology.

Purpose of the Study:

To review recent advances in pediatric migraine.
To focus on epidemiology, diagnostic criteria, and pathophysiology.
To examine management strategies, including neuroimaging and triptan use.

Main Methods:

Review of current literature on pediatric migraine.
Analysis of evolving diagnostic criteria for children.
Examination of evidence for pharmacotherapy, specifically triptans.

Keywords:

Adolescents Children Headache Migraine Sumatriptan Triptans

More Related Videos

An Automated Squint Method for Time-syncing Behavior and Brain Dynamics in Mouse Pain Studies

An Automated Squint Method for Time-syncing Behavior and Brain Dynamics in Mouse Pain Studies

Published on: November 1, 2024

Related Experiment Videos

Last Updated: Jun 17, 2026

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache

Published on: June 2, 2014

An Automated Squint Method for Time-syncing Behavior and Brain Dynamics in Mouse Pain Studies

An Automated Squint Method for Time-syncing Behavior and Brain Dynamics in Mouse Pain Studies

Published on: November 1, 2024

Main Results:

Migraine is a prevalent primary headache disorder in children.
Diagnostic criteria for pediatric migraine are under revision.
Triptans demonstrate efficacy in treating acute pediatric migraines, similar to adults.

Conclusions:

Pediatric migraine management benefits from understanding evolving diagnostic criteria and pathophysiology.
Triptans represent an effective treatment option for acute pediatric migraines.
Further research supports the use of triptans in this population.